Search Research Articles
Browse Research Categories

Semax Peptide Research

Semax is a synthetic heptapeptide analog of the ACTH(4-7) sequence (Met-Glu-His-Phe-Pro-Gly-Pro), developed in Russia and studied for its neuroprotective, nootropic, and neurotrophic properties. Research has documented its ability to upregulate BDNF (brain-derived neurotrophic factor), enhance dopaminergic and serotonergic neurotransmission, improve memory consolidation, and protect neurons from ischemic and oxidative damage. Studies have explored its applications in stroke recovery, cognitive enhancement, anxiety, ADHD-like attention deficits, neuroprotection, and post-injury brain repair. It remains one of the most studied nootropic peptides in the Russian research literature. This section covers scientific studies on Semax and its neurological, cognitive, and neuroprotective peptide research applications.

Other Popular Research Categories

Newest Semax Research

Semax Peptide Research – Complete Guide

Semax is a synthetic heptapeptide derived from a fragment of adrenocorticotropic hormone, studied primarily for its effects on brain-derived neurotrophic factor signaling, neuroprotection, and cognitive function in animal models. Originally developed in Russia and approved there for stroke treatment, Semax research has expanded to cover ischemic injury, memory consolidation, mood regulation, and amyloid-beta modulation. This guide covers semax peptide research...

About The Cenexa Labs Research Library

This section of the research library focuses on scientific studies involving and related research. The Cenexa Research Library compiles publicly available scientific literature and research summaries related to peptides, bioregulators, and signaling molecules. Our goal is to make complex scientific research easier to understand without requiring a technical background.
Scroll to Top
0